MedPath

Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Phase 2
Recruiting
Conditions
Amnestic Mild Cognitive Impairment
Mild Traumatic Brain Injury
Mild Cognitive Impairment
Amnestic Mild Cognitive Disorder
Concussion, Brain
Interventions
Device: High Definition Transcranial Direct Current Stimulation
Registration Number
NCT05446584
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

This study will probe if the biological changes in amnestic mild cognitive impairment (aMCI) are related to a history of mild traumatic brain injury (mTBI) using high definition transcranial direct current stimulation (HD-tDCS) and blood-derived biomarker tools. Participants who Do as well as those who Do Not have a history of mTBI will be enrolled in the study.

Detailed Description

Ten study visits will be completed by each participant. The initial visit will include a blood draw and a baseline memory evaluation. Afterwards, participants will be randomized to begin with one of 3 conditions of HD-tDCS. The three conditions are sham-control, active stimulation to frontal region, and active stimulation to left temporal region. All participants will be expected to completed each HD-tDCS condition, which will be counterbalanced and separated by 14 days. Active HD-tDCS will be applied at 2 mA for 30 minutes over 3 consecutive daily sessions while sham stimulation will be applied for the same duration and timespan. All subjects will complete memory assessments again immediately following each HD-tDCS condition for a total of four test sessions.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
75
Inclusion Criteria
  1. Active diagnosis of amnestic mild cognitive impairment
  2. Presence of an mTBI history for the mTBI+ group; absence of an mTBI history for a control sample
  3. Female and male subjects
  4. All races/ethnicities
  5. Age 55 years and older
  6. Fluent in English
Exclusion Criteria
  1. Mild traumatic brain injury within past year
  2. Lifetime history of moderate or severe brain injury
  3. Lifetime major neurologic syndromes (e.g., stroke, epilepsy, brain tumor)
  4. Lifetime major cardiovascular conditions (e.g., heart attack, heart failure)
  5. Current substance use disorder
  6. Current major psychiatric disorders (e.g., major depressive disorder, bipolar disorder)
  7. Current vision or hearing impairment that interferes with testing
  8. Any electronic and or metallic implants in the skull or brain
  9. Current medication use known to alter HD-tDCS reactivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Active left temporal HD-tDCSHigh Definition Transcranial Direct Current StimulationElectrodes will be placed in a 4x1 ring configuration over the left temporal region in accordance with the International 10-10 EEG system. Stimulation will consist of a ramp up period in which the electrical current is gradually increased, 30 minutes of stimulation at 2 mA, and a ramp down period during which the electrical current is gradually removed. Stimulation will be applied back-to-back over three consecutive days.
Active left frontal HD-tDCSHigh Definition Transcranial Direct Current StimulationElectrodes will be placed in a 4x1 ring configuration over the frontal region in accordance with the International 10-10 EEG system. Stimulation will consist of a ramp up period in which the electrical current is gradually increased, 30 minutes of stimulation at 2 mA, and a ramp down period during which the electrical current is gradually removed. Stimulation will be applied back-to-back over three consecutive days.
Sham HD=tDCSHigh Definition Transcranial Direct Current StimulationElectrodes will be placed in the same 4x1 ring configuration over the frontal region as the active left frontal condition to ensure a useful control condition. Stimulation will consist of a 30-second ramp up period until reaching 2 mA, followed immediately by a 30-second ramp down, and off for 29 minutes. The same ramp up and down process will be repeated in the final minute of the session to help preserve masking of conditions. Sham stimulation will be applied back-to-back over three consecutive days.
Primary Outcome Measures
NameTimeMethod
Changes in Rey Auditory Verbal Learning Test ScoreBaseline and immediately after completion of each HD-tDCS condition

The RAVLT is a verbal episodic memory test that is sensitive to mesial and lateral verbal episodic memory circuit dysfunction. The primary outcome measure for this task is the total number of items immediately recalled during the learning trials and after the 20 minute delayed recall trial. Changes in scores from baseline to testing immediately following the completion of each condition will be examined.

Secondary Outcome Measures
NameTimeMethod
Changes in Delis Kaplan Executive Function System (DKEFS) Trail Making TestBaseline and immediately after completion of each HD-tDCS condition

The DKEFS Trail Making Test is a measure of cognitive flexibility and executive functions. The task requires the subject to as quickly as possible complete five conditions, involving number cancellation, number sequencing, letter sequencing, number-letter switching, and line tracing. The outcome measure for this task is the time to complete each of the five conditions. Changes in scores from baseline to testing immediately following the completion of each condition will be examined.

Changes in Delis Kaplan Executive Function System (DKEFS) Color-Word Interference TestBaseline and immediately after completion of each HD-tDCS condition

The DKEFS Color-Word Interference test is a measure of information processing speed and complex attention. The task requires the subject to as quickly as possible complete four conditions, involving color naming, word reading, response inhibition, and then switching back-and-forth between two response patterns. The outcome measure for this task is the time to complete each of the four conditions. Changes in scores from baseline to testing immediately following the completion of each condition will be examined.

Trial Locations

Locations (1)

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath